I'm not sure what point you have to continue dismissing me for some nutto. I believe I already apologized for my over ambitious posts initially. I got excited with the news from KK and presumptuously assumed it was regarding the most recent upcoming meeting, rather than one specifically regarding HIV mono, ideally post BLA submission if remaining on schedule. If I was able to post screenshots of my accounts at Schwab and Fidelity showing my shares owned of Cytodyn and 4 other pharma's, with their respective purchase dates and price points, you would see that I have not sold any shares to date, and have been buying up stock in Cydy sporadically at multiple price points since Feb. 2019 (which was shortly after I was made aware of upcoming meetings...more preliminary in nature). Not only have a not sold a single share of Cydy, the only stocks I've actually sold in the last 6 months was CSCO and INTC, mostly to up my collateral in Cydy and another pharma.

If you don't want to trust what I say that's fine. I only mentioned what I know as a courtesy.

Would you not agree that Cydy Stock price has remained relatively stable? It has been fairly stable no matter if it's doing volume of 100-200k a day or 500-700k. It seems to level itself back towards its baseline. So if I'm right, huge win. If I'm wrong, this will not be a needle mover and will once again stay around baseline. Cytodyn isn't making any wild jumps in share price just because of some news, nor will a hypothetical be a needle mover...until after it's official. If you actually have followed Cydy, you will see what I'm saying is accurate. There is no upside of me being incorrect, it certainly doesn't benefit my shares.